Session date: 
07/08/2026 - 12:00pm to 1:00pm

Presenters:

Stephen M. Ansell, M.D., Ph.D.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Define the components of an effective T-cell mediated immune response.
  • Identify barriers to an effective immune response in lymphoma and determine why they matter.
  • Describe strategies to overcome the immune deficiencies including the use of CART cells, immune checkpoint inhibitors and bispecific antibodies.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Stephen M. Ansell, M.D., Ph.D.
Co-presenter: 
Laura Raffals, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota